ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 63839 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 63839; 2) Community: the network communities that were significantly associated with the response to NSC 63839; 3) Molecule: the relationships between components within communities and NSC 63839; 4) MDR: the compounds that were significantly associated with the NSC 63839.

NSC Compound Enrichment Correlation
NSC 673464 Null 0.0137891122538509 0.23514818
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0137891122538509 0.59630448
NSC 697730 Null 0.0137891122538509 0.29572289
NSC 703468 Null 0.0137891122538509 0.37001937
NSC 718370 Null 0.0137891122538509 -0.13257527
NSC 728133 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,5-dichlorobenzene 0.0137891122538509 0.19523865
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.0137891122538509 0.43512629
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.013789112253851 0.12437361
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.013789112253851 0.38665259
NSC 328410 Camptothecin Derivative 0.013789112253851 -0.00091655458
Total:56  Current:20    [First] [Prev] [Next] [Last]